CHGA — Change Agents Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.47 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -65.85% | ||
| Return on Equity | n/a | ||
| Operating Margin | -1905.06% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.39 | 1.2 | 1.26 | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Change Agents Corp., formerly Avalon GloboCare Corp., is an artificial intelligence software company. The Company is focused on developing agentic artificial intelligence (AI) applications designed to help small businesses, brands, and content creators increase revenue, improve digital discoverability, and automate content creation. The Company's portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its Software-as-a-Service (SaaS) business model, the Company is focused on delivering innovative AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns. The Company is also distributing the KetoAir breathalyzer device, a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America.
Directors
- Wenzhao Lu CHM (63)
- David Jin PRE (53)
- Luisa Ingargiola CFO (52)
- Meng Li COO (43)
- Wilbert Tauzin DRC (77)
- Yue Li IND (47)
- Yancen Lu IND (46)
- Steven Sanders IND (75)
- William Stilley IND (53)
- Tevi Troy IND (53)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- July 28th, 2014
- Public Since
- February 22nd, 2016
- No. of Shareholders
- 240
- No. of Employees
- 2
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 1,120,216
- Address
- 4400 ROUTE 9, SUITE 3100, FREEHOLD, 07728
- Web
- https://ir.changeagentscorp.com
- Phone
- +1 3026587581
- Auditors
- M&K CPAS, PLLC
Latest News for CHGA
Upcoming Events for CHGA
Q3 2026 Change Agents Corp Earnings Release
Q4 2026 Change Agents Corp Earnings Release
Similar to CHGA
20/20 Biolabs
NASDAQ Capital Market
Accuray Incorporated
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
AdaptHealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
FAQ
As of Today at 01:54 UTC, shares in Change Agents are trading at $1.71. This share price information is delayed by 15 minutes.
Shares in Change Agents last closed at $1.71 and the price had moved by -96.18% over the past 365 days. In terms of relative price strength the Change Agents share price has underperformed the S&P500 Index by -96.73% over the past year.
There is no consensus recommendation for this security.
Find out moreChange Agents does not currently pay a dividend.
Change Agents does not currently pay a dividend.
Change Agents does not currently pay a dividend.
To buy shares in Change Agents you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.71, shares in Change Agents had a market capitalisation of $1.92m.
Here are the trading details for Change Agents:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: CHGA
Based on an overall assessment of its quality, value and momentum Change Agents is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Change Agents. Over the past six months, its share price has underperformed the S&P500 Index by -82.52%.
As of the last closing price of $1.71, shares in Change Agents were trading -81.02% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Change Agents PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Change Agents' management team is headed by:
- Wenzhao Lu - CHM
- David Jin - PRE
- Luisa Ingargiola - CFO
- Meng Li - COO
- Wilbert Tauzin - DRC
- Yue Li - IND
- Yancen Lu - IND
- Steven Sanders - IND
- William Stilley - IND
- Tevi Troy - IND